Dr. Tapan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
810 Harrison Ave
Boston, MA 02118- Is this information wrong?
Summary
- Dr. Umit Tapan is a thoracic medical oncologist in Boston, MA. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 11 years. He also speaks multiple languages, including Turkish. He specializes in thoracic cancer and is experienced in thoracic cancer and medical oncology.
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2015
Steward Carney HospitalResidency, Internal Medicine, 2010 - 2012- Steward Carney HospitalInternship, Internal Medicine, 2009 - 2010
- Hacettepe University HospitalMD, Internal Medicine Residency, 2006 - 2009
Hacettepe University FOMClass of 2006
Certifications & Licensure
MA State Medical License 2015 - 2026
NH State Medical License 2015 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Plasma-Adapted First-Line Pembro In NSCLC Start of enrollment: 2020 Jan 13
Publications & Presentations
PubMed
- Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.Laura Burns, Hanna Tukachinsky, Kira Raskina, Richard S P Huang, Alexa B Schrock, Jacob Sands, Matthew H Kulke, Geoffrey R Oxnard, Umit Tapan> ;Lung Cancer. 2024 Feb 1
- Disparities in Lung Cancer Clinical Trial Discussion and Enrollment at a Safety Net Hospital.Al Omari, O., Patel, M., Kilic, S., Zhao, J., Dudipala, H., Burns, L., Jani, C., Radwan, A., Mak, K., Suzuki, K., Tapan, U.> ;Community Health Equity Research & Policy. 2023 Dec 12
- Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley, Karen L Reckamp, Hina Khan, Mary Jo Fidler, Christine M Bestvina, Julie Brahm...> ;Lung Cancer. 2023 Dec 1
- Join now to see all
Journal Articles
- Postural epigastric pain; a challenging symptom for Cytomegalovirus (CMV) gastritisTapan U, Aybal A, Arici M, Altun B, Renal Failure, 2/1/2012
- Multimodality treatment in the management of anorectal melanomaTapan U, Dizdar O, Bulut N, Celik I, EAJM, 12/1/2011
- New advances in the diagnosis, medical management and follow-up of medullary thyroid cancerDokmetas HS, Kilicli F, Ozben V, Tapan U, Cumhuriyet Med J, 12/1/2011
- Join now to see all
Abstracts/Posters
- Outcome of patients with positive heparin-platelet factor 4 antibodies: A retrospective observational studyTapan U, Bolla S, Daglilar ES, Chang S, Kozyreva O, 55th Annual ASH Meeting, New Orleans, LA, 12/1/2013
- EBV-associated large B cell lymphoma arising in an atrial myxomaTapan U, Pestana JB, Lee JC, Lerner A, Massachusetts Society of Clinical Oncologists (MSCO) Annual Meeting, Boston, MA, 11/1/2013
- Pazopanib Induced Hepatotoxicity in Metastatic Renal Cell Cancer PatientsTapan U, Tammaro KA, Meehan R, Jacobson DR, Hankins M, Massachusetts Society of Clinical Oncologists (MSCO) Annual Meeting, Boston, MA, 11/1/2012
- Join now to see all
Professional Memberships
- Associate Member
- Member
- Member
Other Languages
- Turkish
Hospital Affiliations
Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
